Skip to main content

Verdence Capital Advisors LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1719305 HUNT VALLEY, MD

Position in HALO

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$977,435
+$175,571 QoQ
Shares Held
12,488
+0.7% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#86
of 266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verdence Capital Advisors LLC holds $3,978,199 across 8 Biotechnology names. HALO ranks #2 (24.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 HALO
Halozyme Therapeutics, Inc.
This page
12,488 $977,435

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $977,435 12,488
2026-03-31 $801,864 12,407
2025-12-31 $830,885 12,346
2025-09-30 $955,253 13,025
2025-06-30 $704,194 13,537
2025-03-31 $867,879 13,601
2024-12-31 $632,574 13,231
2024-09-30 $757,399 13,232
2024-06-30 $679,632 12,980
2024-03-31 $530,467 13,040
2023-12-31 $538,655 14,574
2023-09-30 $551,378 14,434
2023-06-30 $527,487 14,624
2023-03-31 $550,623 14,418
2022-12-31 $839,957 14,762
2022-09-30 $619,829 15,676
2022-06-30 $683,232 15,528
2022-03-31 $559,157 14,021
2021-12-31 $553,691 13,770
2021-09-30 $467,331 11,488
2021-06-30 $521,987 11,495
2021-03-31 $480,727 11,531
2020-12-31 $493,343 11,551
2020-09-30 $299,276 11,388
2020-06-30 $305,312 11,388
2020-03-31 $204,870 11,388